7–9 week old male mice were treated with vehicle (V) or 9-PAHSA (9P, 15mg/kg/d, oral gavage) for 26 days. Serum (A) and WAT (B) PAHSA levels (n=4–5/group).
Body weight (C), fat mass (D), and ad lib-fed serum insulin (E), and TG (F) levels after 26 days of treatment.
(G) ITT (0.5U/kg, i.p.) after 14 days of treatment.
(C–G) n=7–10/group
(H) Numbers of total, TNFα+ and IL-1β+ ATMs in PG WAT of AdChREBP KO mice after 26 days of treatment (n=5/group).
Data are mean±SEM. *p< 0.05 vs. ChREBPfl/fl, same treatment; #p< 0.05 vs. vehicle. (also see Fig S7)